Literature DB >> 20450373

Assessment of the effects of dentifrice on periodontal disease biomarkers in gingival crevicular fluid.

Virginia M Barnes1, Ricardo Teles, Harsh M Trivedi, William Devizio, Tao Xu, Douglas P Lee, Matthew W Mitchell, Jacob E Wulff, Michael V Milburn, Lining Guo.   

Abstract

BACKGROUND: Periodontal disease has been studied primarily from clinical outcomes in lengthy human studies. Comprehensive biochemical profiling (metabolomics) has become a powerful tool for disease characterization and biomarker discovery. In a previous study, we performed a metabolomic analysis of gingival crevicular fluid collected from healthy, gingivitis, and periodontitis sites. Many metabolites associated with inflammation, oxidative stress, tissue degradation, and bacterial metabolism were found to be significantly induced by the diseases.
METHODS: A panel of 10 markers was selected from the previous metabolomic study based on their statistical significance. Thirty-nine chronic periodontitis subjects were randomly assigned to a toothpaste regimen: control dentifrice (n = 21) or triclosan-containing dentifrice ([CT] n = 18). Subjects were instructed to use their assigned dentifrice twice daily for 6 weeks. Gingival crevicular fluid samples from six healthy, six gingivitis, and three periodontitis sites were collected from each subject at baseline, 1 week, and 6 weeks. The relative levels of the markers in the samples were determined by mass spectrometry. One-sided matched-paired t tests were performed to compare data from healthy, gingivitis, and periodontitis sites.
RESULTS: Statistical analysis indicates that CT significantly decreased the levels of inosine, lysine, putrescine, and xanthine at the gingivitis sites as early as week 1. In contrast, control dentifrice had little effect.
CONCLUSIONS: This result provides biochemical confirmation for the therapeutic effects of CT on gingivitis. Biomarkers were significantly altered by CT before clinical changes were observed, suggesting that the markers have predicative value for disease state assessment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20450373     DOI: 10.1902/jop.2010.100070

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  5 in total

1.  Metabolomic Analysis of Gingival Crevicular Fluid Using Gas Chromatography/Mass Spectrometry.

Authors:  Miho Ozeki; Takenori Nozaki; Jun Aoki; Takeshi Bamba; Kirk R Jensen; Shinya Murakami; Michisato Toyoda
Journal:  Mass Spectrom (Tokyo)       Date:  2016-06-27

2.  Triclosan toothpaste as an adjunct therapy to plaque control in children from periodontitis families: a crossover clinical trial.

Authors:  Mabelle Freitas Monteiro; Henrique Tonelli; Aurélio Amorim Reis; Marcio Zaffalon Casati; Karina Gonzales Silvério; Francisco Humberto Nociti Junior; Enilson Antônio Sallum; Renato Corrêa Viana Casarin
Journal:  Clin Oral Investig       Date:  2020-01-06       Impact factor: 3.573

3.  Global metabolomic analysis of human saliva and plasma from healthy and diabetic subjects, with and without periodontal disease.

Authors:  Virginia M Barnes; Adam D Kennedy; Fotinos Panagakos; William Devizio; Harsh M Trivedi; Thomas Jönsson; Lining Guo; Shannon Cervi; Frank A Scannapieco
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

Review 4.  Metabolomics for the masses: The future of metabolomics in a personalized world.

Authors:  Drupad K Trivedi; Katherine A Hollywood; Royston Goodacre
Journal:  New Horiz Transl Med       Date:  2017-03

5.  Changes in the Salivary Metabolic Profile of Generalized Periodontitis Patients after Non-surgical Periodontal Therapy: A Metabolomic Analysis Using Nuclear Magnetic Resonance Spectroscopy.

Authors:  Filippo Citterio; Federica Romano; Gaia Meoni; Giovanni Iaderosa; Silvia Grossi; Alberto Sobrero; Francesca Dego; Matteo Corana; Giovanni Nicolao Berta; Leonardo Tenori; Mario Aimetti
Journal:  J Clin Med       Date:  2020-12-08       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.